Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nature ; 440(7086): 954-8, 2006 Apr 13.
Artigo em Inglês | MEDLINE | ID: mdl-16612388

RESUMO

A guiding hypothesis for cell-cycle regulation asserts that regulated proteolysis constrains the directionality of certain cell-cycle transitions. Here we test this hypothesis for mitotic exit, which is regulated by degradation of the cyclin-dependent kinase 1 (Cdk1) activator, cyclin B. Application of chemical Cdk1 inhibitors to cells in mitosis induces cytokinesis and other normal aspects of mitotic exit, including cyclin B degradation. However, chromatid segregation fails, resulting in entrapment of chromatin in the midbody. If cyclin B degradation is blocked with a proteasome inhibitor or by expression of non-degradable cyclin B, Cdk inhibitors will nonetheless induce mitotic exit and cytokinesis. However, if after mitotic exit, the Cdk1 inhibitor is washed free from cells in which cyclin B degradation is blocked, the cells can revert back to M phase. This reversal is characterized by chromosome recondensation, nuclear envelope breakdown, assembly of microtubules into a mitotic spindle, and in most cases, dissolution of the midbody, reopening of the cleavage furrow, and realignment of chromosomes at the metaphase plate. These findings demonstrate that proteasome-dependent degradation of cyclin B provides directionality for the M phase to G1 transition.


Assuntos
Mitose/fisiologia , Xenopus , Animais , Proteína Quinase CDC2/antagonistas & inibidores , Proteína Quinase CDC2/metabolismo , Linhagem Celular , Células Cultivadas , Ciclina B/metabolismo , Citocinese/efeitos dos fármacos , Flavonoides/farmacologia , Fase G1/efeitos dos fármacos , Células HeLa , Humanos , Queratinócitos/citologia , Queratinócitos/efeitos dos fármacos , Queratinócitos/enzimologia , Queratinócitos/metabolismo , Metáfase/efeitos dos fármacos , Mitose/efeitos dos fármacos , Modelos Biológicos , Nocodazol/farmacologia , Piperidinas/farmacologia , Complexo de Endopeptidases do Proteassoma/metabolismo
2.
J Cell Biol ; 158(1): 23-9, 2002 Jul 08.
Artigo em Inglês | MEDLINE | ID: mdl-12105179

RESUMO

A stable cell line (GT2-LPk) derived from LLC-Pk was created in which endogenous DNA topoisomerase II alpha (topoII alpha) protein was downregulated and replaced by the expression of topoII alpha fused with enhanced green fluorescent protein (EGFP-topoII alpha). The EGFP-topoII alpha faithfully mimicked the distribution of the endogenous protein in both interphase and mitosis. In early stages of mitosis, EGFP-topoII alpha accumulated at kinetochores and in axial lines extending along the chromosome arms. During anaphase, EGFP-topoII alpha diminished at kinetochores and increased in the cytoplasm with a portion accumulating into large circular foci that were mobile and appeared to fuse with the reforming nuclei. These cytoplasmic foci appearing at anaphase were coincident with precursor organelles of the reforming nucleolus called nucleolus-derived foci (NDF). Photobleaching of EGFP-topoII alpha associated with kinetochores and chromosome arms showed that the majority of the protein rapidly exchanges (t1/2 of 16 s). Catalytic activity of topoII alpha was essential for rapid dynamics, as ICRF-187, an inhibitor of topoII alpha, blocked recovery after photobleaching. Although some topoII alpha may be stably associated with chromosomes, these studies indicate that the majority undergoes rapid dynamic exchange. Rapid mobility of topoII alpha in chromosomes may be essential to resolve strain imparted during chromosome condensation and segregation.


Assuntos
Cromossomos/metabolismo , DNA Topoisomerases Tipo II/metabolismo , Cinetocoros/metabolismo , Animais , Antígenos de Neoplasias , Western Blotting , Linhagem Celular , Cromossomos/ultraestrutura , Citoplasma/metabolismo , Proteínas de Ligação a DNA , Regulação para Baixo , Proteínas de Fluorescência Verde , Lasers , Proteínas Luminescentes/metabolismo , Microscopia de Fluorescência , Mitose , Testes de Precipitina , Proteínas Recombinantes de Fusão/metabolismo , Frações Subcelulares/metabolismo , Suínos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...